Oligodendroglia and Myelin in Neurodegenerative Diseases: More Than Just Bystanders?

por Ettle, Benjamin, Schlachetzki, Johannes C. M., Winkler, Jürgen
Publicado 2015

Immune Response to SARS-CoV-2 mRNA Vaccines in an Open-Label Multicenter Study in Participants with Relapsing Multiple Sclerosis Treated with Ofatumumab

por Ziemssen, Tjalf, Groth, Marie, Ettle, Benjamin, Bopp, Tobias
Publicado 2022

Results on SARS-CoV-2 mRNA Vaccine Booster from an Open-Label Multicenter Study in Ofatumumab-Treated Participants with Relapsing Multiple Sclerosis

por Ziemssen, Tjalf, Schlegel, Eugen, Groth, Marie, Ettle, Benjamin, Bopp, Tobias
Publicado 2023

α-Synuclein deficiency promotes neuroinflammation by increasing Th1 cell-mediated immune responses

por Ettle, Benjamin, Kuhbandner, Kristina, Jörg, Stefanie, Hoffmann, Alana, Winkler, Jürgen, Linker, Ralf A.
Publicado 2016

The Multiple Sclerosis Health Resource Utilization Survey (MS-HRS): Development and Validation Study

por Ness, Nils-Henning, Haase, Rocco, Kern, Raimar, Schriefer, Dirk, Ettle, Benjamin, Cornelissen, Christian, Akguen, Katja, Ziemssen, Tjalf
Publicado 2020

Descriptive Analysis of Real-World Data on Fingolimod Long-Term Treatment of Young Adult RRMS Patients

por Ziemssen, Tjalf, Albrecht, Holger, Haas, Judith, Klotz, Luisa, Lang, Michael, Lassek, Christoph, Schmidt, Stephan, Ettle, Benjamin, Schulze-Topphoff, Ulf
Publicado 2021

Comparing the long-term clinical and economic impact of ofatumumab versus dimethyl fumarate and glatiramer acetate in patients with relapsing multiple sclerosis: A cost-consequence...

por Koeditz, Dominik, Frensch, Juergen, Bierbaum, Martin, Ness, Nils-Henning, Ettle, Benjamin, Vudumula, Umakanth, Gudala, Kapil, Adlard, Nicholas, Tiwari, Santosh, Ziemssen, Tjalf
Publicado 2022

Oligodendroglial α‐synucleinopathy‐driven neuroinflammation in multiple system atrophy

por Hoffmann, Alana, Ettle, Benjamin, Battis, Kristina, Reiprich, Simone, Schlachetzki, Johannes C. M., Masliah, Eliezer, Wegner, Michael, Kuhlmann, Tanja, Riemenschneider, Markus J., Winkler, Jürgen
Publicado 2019

Long-term real-world effectiveness and safety of fingolimod over 5 years in Germany

por Ziemssen, Tjalf, Lang, Michael, Schmidt, Stephan, Albrecht, Holger, Klotz, Luisa, Haas, Judith, Lassek, Christoph, Lang, Stefan, Winkelmann, Veronika E., Ettle, Benjamin, Schulze-Topphoff, Ulf
Publicado 2022